Abbott raised to outperform by Leerink Partners; price target raised to $124 from $106
ABT•Leerink Partners raised its rating on Abbott to outperform from market perform and its price target to $124 from $106.
ABT•Leerink Partners raised its rating on Abbott to outperform from market perform and its price target to $124 from $106.
